These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
134 related items for PubMed ID: 14640963
1. H2O2-induced platelet aggregation and increase in intracellular Ca2+ concentration are blocked by inhibitors of intracellular signaling. Loiko EN, Samal AB, Shulyakovskaya SM. Biochemistry (Mosc); 2003 Nov; 68(11):1210-6. PubMed ID: 14640963 [Abstract] [Full Text] [Related]
2. Effect of 17beta-estradiol on inhibition of platelet aggregation in vitro is mediated by an increase in NO synthesis. Nakano Y, Oshima T, Matsuura H, Kajiyama G, Kambe M. Arterioscler Thromb Vasc Biol; 1998 Jun; 18(6):961-7. PubMed ID: 9633938 [Abstract] [Full Text] [Related]
3. Multifaceted effects of arachidonic acid and interaction with cyclic nucleotides in human platelets. Rukoyatkina N, Shpakova V, Panteleev M, Kharazova A, Gambaryan S, Geiger J. Thromb Res; 2018 Nov; 171():22-30. PubMed ID: 30240944 [Abstract] [Full Text] [Related]
4. Inhibitory effect of 8-bromo cyclic GMP on an extracellular Ca2+-dependent arachidonic acid liberation in collagen-stimulated rabbit platelets. Matsuoka I, Nakahata N, Nakanishi H. Biochem Pharmacol; 1989 Jun 01; 38(11):1841-7. PubMed ID: 2544181 [Abstract] [Full Text] [Related]
5. Antiplatelet effect of marchantinquinone, isolated from Reboulia hemisphaerica, in rabbit washed platelets. Liao CH, Ko FN, Wu CL, Teng CM. J Pharm Pharmacol; 2000 Mar 01; 52(3):353-9. PubMed ID: 10757426 [Abstract] [Full Text] [Related]
6. p-Aminobenzoic acid and its metabolite p-acetamidobenzoic acid inhibit agonist-induced aggregation and arachidonic acid-induced [Ca2+]i transients in human platelets. Barbieri B, Stain-Malmgren R, Papadogiannakis N. Thromb Res; 1999 Sep 01; 95(5):235-43. PubMed ID: 10515288 [Abstract] [Full Text] [Related]
7. Antiplatelet effect of demethyldiisoeugenol. Liao CH, Ko FN, Kuo YH, Teng CM. Can J Physiol Pharmacol; 1996 Oct 01; 74(10):1111-6. PubMed ID: 9022830 [Abstract] [Full Text] [Related]
8. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative. Cherng SC, Huang WH, Shiau CY, Lee AR, Chou TC. Eur J Pharmacol; 2006 Feb 17; 532(1-2):32-7. PubMed ID: 16457809 [Abstract] [Full Text] [Related]
9. [Drugs interfering with platelet function]. Marino A, De Natale G. Clin Ter; 1990 Feb 15; 132(3):193-9. PubMed ID: 2159394 [Abstract] [Full Text] [Related]
10. Factors affecting platelet cyclic GMP levels during aggregation induced by collagen and by arachidonic acid. Davies T, Davidson MM, McClenaghan MD, Say A, Haslam RJ. Thromb Res; 1976 Oct 15; 9(4):387-405. PubMed ID: 185743 [No Abstract] [Full Text] [Related]
11. Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. Anfossi G, Russo I, Massucco P, Mattiello L, Balbo A, Cavalot F, Trovati M. Thromb Res; 2001 May 15; 102(4):319-30. PubMed ID: 11369425 [Abstract] [Full Text] [Related]
12. Effects of combination therapy with low-dose aspirin and warfarin on platelet functions after heart valve replacement. Kobune K, Inoue M, Morikawa M, Tsuboi M, Takanami Y, Iwane Y, Kudo T. Res Commun Chem Pathol Pharmacol; 1991 Nov 15; 74(2):153-65. PubMed ID: 1811279 [Abstract] [Full Text] [Related]
13. Intracellular levels of cyclic AMP and cyclic GMP differentially modify platelet aggregate size in human platelets activated with epinephrine or ADP. Qi R, Ozaki Y, Satoh K, Yang LB, Asazuma N, Yatomi Y, Kume S. J Cardiovasc Pharmacol; 1996 Aug 15; 28(2):215-22. PubMed ID: 8856476 [Abstract] [Full Text] [Related]
14. Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost. Anfossi G, Massucco P, Mularoni E, Cavalot F, Mattiello L, Trovati M. Prostaglandins Leukot Essent Fatty Acids; 1993 Nov 15; 49(5):839-45. PubMed ID: 7508131 [Abstract] [Full Text] [Related]
15. Antiplatelet mechanisms of TA-993 and its metabolite MB3 in ADP-induced platelet aggregation. Katoh M, Karasawa T, Doi H, Odawara A, Takagi M, Ikeo T, Narita H. Eur J Pharmacol; 2000 Jul 07; 399(2-3):91-6. PubMed ID: 10884507 [Abstract] [Full Text] [Related]
16. Cyclic AMP and cyclic GMP phosphodiesterase inhibition by an antiplatelet agent, 6-[(3-methylene-2-oxo-5-phenyl-5-tetrahydrofuranyl)methoxy)quinol inone (CCT-62). Liao CH, Tzeng CC, Teng CM. Eur J Pharmacol; 1998 May 15; 349(1):107-14. PubMed ID: 9669503 [Abstract] [Full Text] [Related]
17. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets. Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC. Eur J Pharmacol; 2005 Dec 19; 527(1-3):37-43. PubMed ID: 16313903 [Abstract] [Full Text] [Related]
18. Adenosine diphosphate-induced aggregation is enhanced in platelets obtained from patients with thrombotic primary antiphospholipid syndrome (t-PAPS): Role of P2Y12 -cAMP signaling pathway. Leonardi GR, Lescano CH, Costa JL, Mazetto B, Orsi FA, Monica FZ. J Thromb Haemost; 2022 Jul 19; 20(7):1699-1711. PubMed ID: 35395698 [Abstract] [Full Text] [Related]
19. Mechanisms of satigrel (E5510), a new anti-platelet drug, in inhibiting human platelet aggregation. Selectivity and potency against prostaglandin H synthases isozyme activities and phosphodiesterase isoform activities. Nagakura N, Saeki T, Harada K, Yoshitake S, Kobayashi S, Yamanaka T, Saito I. Biol Pharm Bull; 1996 Jun 19; 19(6):828-33. PubMed ID: 8799481 [Abstract] [Full Text] [Related]
20. Inhibitory effect of GBH on platelet aggregation through inhibition of intracellular Ca2+ mobilization in activated human platelets. Park WH, Kim HK, Nam KS, Shon YH, Jeon BH, Moon SK, Kim MG, Kim CH. Life Sci; 2004 Nov 05; 75(25):3063-76. PubMed ID: 15474558 [Abstract] [Full Text] [Related] Page: [Next] [New Search]